Healthcare Analysts provide expert insights on current and emerging treatments for Systemic Mastocytosis (relevant companies Blueprint Medicines (BPMC) and Cogent Biosciences (COGT) on an Analyst/Industry conference call to be held on March 25 at 2 pm. Webcast Link
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BPMC:
- JPMorgan healthcare analysts hold an analyst/industry conference call
- Blueprint Medicines: Strong Growth, Strategic M&A Potential, and Promising Pipeline Drive Positive Outlook
- Blueprint Medicines assumed with an Equal Weight at Morgan Stanley
- Balanced Outlook on Blueprint Medicines: Growth Prospects and Market Dynamics
- Coinbase initiated, Block upgraded: Wall Street’s top analyst calls